A large number of reports describe an enhanced expression of FAK protein in a variety of human cancers, including sarcomas, astrocytomas and carcinomas of the breast, colon, thyroid, prostate, oral cavity, liver, stomach and ovary (see (McLean et al, 2005) and references herein). This evidence concerns the gene PTK2 and cancer.